The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global POC Infectious Diseases Market Research Report 2025
Synopsis
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
The global POC Infectious Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
This report aims to provide a comprehensive presentation of the global market for POC Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Infectious Diseases.
Report Scope
The POC Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global POC Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POC Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Cepheid
Diamedix
Diasorin
Eiken Chemical
Enzo Biochem
Segment by Type
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV
Segment by Application
Hospital& Clinics
Clinical Diagnostic Laboratories
Homecare Settings
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of POC Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
The global POC Infectious Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
This report aims to provide a comprehensive presentation of the global market for POC Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Infectious Diseases.
Report Scope
The POC Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global POC Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POC Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Cepheid
Diamedix
Diasorin
Eiken Chemical
Enzo Biochem
Segment by Type
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV
Segment by Application
Hospital& Clinics
Clinical Diagnostic Laboratories
Homecare Settings
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of POC Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POC Infectious Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Flu
1.2.3 Adenovirus
1.2.4 Malaria
1.2.5 Streptococcal Bacteremia
1.2.6 Tuberculosis (TB)
1.2.7 Occult Blood
1.2.8 HIV
1.3 Market by Application
1.3.1 Global POC Infectious Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital& Clinics
1.3.3 Clinical Diagnostic Laboratories
1.3.4 Homecare Settings
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global POC Infectious Diseases Market Perspective (2019-2030)
2.2 POC Infectious Diseases Growth Trends by Region
2.2.1 Global POC Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 POC Infectious Diseases Historic Market Size by Region (2019-2024)
2.2.3 POC Infectious Diseases Forecasted Market Size by Region (2025-2030)
2.3 POC Infectious Diseases Market Dynamics
2.3.1 POC Infectious Diseases Industry Trends
2.3.2 POC Infectious Diseases Market Drivers
2.3.3 POC Infectious Diseases Market Challenges
2.3.4 POC Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POC Infectious Diseases Players by Revenue
3.1.1 Global Top POC Infectious Diseases Players by Revenue (2019-2024)
3.1.2 Global POC Infectious Diseases Revenue Market Share by Players (2019-2024)
3.2 Global POC Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by POC Infectious Diseases Revenue
3.4 Global POC Infectious Diseases Market Concentration Ratio
3.4.1 Global POC Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POC Infectious Diseases Revenue in 2023
3.5 POC Infectious Diseases Key Players Head office and Area Served
3.6 Key Players POC Infectious Diseases Product Solution and Service
3.7 Date of Enter into POC Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 POC Infectious Diseases Breakdown Data by Type
4.1 Global POC Infectious Diseases Historic Market Size by Type (2019-2024)
4.2 Global POC Infectious Diseases Forecasted Market Size by Type (2025-2030)
5 POC Infectious Diseases Breakdown Data by Application
5.1 Global POC Infectious Diseases Historic Market Size by Application (2019-2024)
5.2 Global POC Infectious Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America POC Infectious Diseases Market Size (2019-2030)
6.2 North America POC Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America POC Infectious Diseases Market Size by Country (2019-2024)
6.4 North America POC Infectious Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe POC Infectious Diseases Market Size (2019-2030)
7.2 Europe POC Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe POC Infectious Diseases Market Size by Country (2019-2024)
7.4 Europe POC Infectious Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific POC Infectious Diseases Market Size (2019-2030)
8.2 Asia-Pacific POC Infectious Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific POC Infectious Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific POC Infectious Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America POC Infectious Diseases Market Size (2019-2030)
9.2 Latin America POC Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America POC Infectious Diseases Market Size by Country (2019-2024)
9.4 Latin America POC Infectious Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POC Infectious Diseases Market Size (2019-2030)
10.2 Middle East & Africa POC Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa POC Infectious Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa POC Infectious Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott POC Infectious Diseases Introduction
11.1.4 Abbott Revenue in POC Infectious Diseases Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Meridian Bioscience
11.2.1 Meridian Bioscience Company Detail
11.2.2 Meridian Bioscience Business Overview
11.2.3 Meridian Bioscience POC Infectious Diseases Introduction
11.2.4 Meridian Bioscience Revenue in POC Infectious Diseases Business (2019-2024)
11.2.5 Meridian Bioscience Recent Development
11.3 Orasure Technologies
11.3.1 Orasure Technologies Company Detail
11.3.2 Orasure Technologies Business Overview
11.3.3 Orasure Technologies POC Infectious Diseases Introduction
11.3.4 Orasure Technologies Revenue in POC Infectious Diseases Business (2019-2024)
11.3.5 Orasure Technologies Recent Development
11.4 Trinity Biotech
11.4.1 Trinity Biotech Company Detail
11.4.2 Trinity Biotech Business Overview
11.4.3 Trinity Biotech POC Infectious Diseases Introduction
11.4.4 Trinity Biotech Revenue in POC Infectious Diseases Business (2019-2024)
11.4.5 Trinity Biotech Recent Development
11.5 Beckman Coulter/ Danaher
11.5.1 Beckman Coulter/ Danaher Company Detail
11.5.2 Beckman Coulter/ Danaher Business Overview
11.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Introduction
11.5.4 Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2019-2024)
11.5.5 Beckman Coulter/ Danaher Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Detail
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson POC Infectious Diseases Introduction
11.6.4 Becton Dickinson Revenue in POC Infectious Diseases Business (2019-2024)
11.6.5 Becton Dickinson Recent Development
11.7 Biomerieux
11.7.1 Biomerieux Company Detail
11.7.2 Biomerieux Business Overview
11.7.3 Biomerieux POC Infectious Diseases Introduction
11.7.4 Biomerieux Revenue in POC Infectious Diseases Business (2019-2024)
11.7.5 Biomerieux Recent Development
11.8 Bio-Rad
11.8.1 Bio-Rad Company Detail
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad POC Infectious Diseases Introduction
11.8.4 Bio-Rad Revenue in POC Infectious Diseases Business (2019-2024)
11.8.5 Bio-Rad Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Detail
11.9.2 Cepheid Business Overview
11.9.3 Cepheid POC Infectious Diseases Introduction
11.9.4 Cepheid Revenue in POC Infectious Diseases Business (2019-2024)
11.9.5 Cepheid Recent Development
11.10 Diamedix
11.10.1 Diamedix Company Detail
11.10.2 Diamedix Business Overview
11.10.3 Diamedix POC Infectious Diseases Introduction
11.10.4 Diamedix Revenue in POC Infectious Diseases Business (2019-2024)
11.10.5 Diamedix Recent Development
11.11 Diasorin
11.11.1 Diasorin Company Detail
11.11.2 Diasorin Business Overview
11.11.3 Diasorin POC Infectious Diseases Introduction
11.11.4 Diasorin Revenue in POC Infectious Diseases Business (2019-2024)
11.11.5 Diasorin Recent Development
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Detail
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical POC Infectious Diseases Introduction
11.12.4 Eiken Chemical Revenue in POC Infectious Diseases Business (2019-2024)
11.12.5 Eiken Chemical Recent Development
11.13 Enzo Biochem
11.13.1 Enzo Biochem Company Detail
11.13.2 Enzo Biochem Business Overview
11.13.3 Enzo Biochem POC Infectious Diseases Introduction
11.13.4 Enzo Biochem Revenue in POC Infectious Diseases Business (2019-2024)
11.13.5 Enzo Biochem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global POC Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Flu
Table 3. Key Players of Adenovirus
Table 4. Key Players of Malaria
Table 5. Key Players of Streptococcal Bacteremia
Table 6. Key Players of Tuberculosis (TB)
Table 7. Key Players of Occult Blood
Table 8. Key Players of HIV
Table 9. Global POC Infectious Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global POC Infectious Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global POC Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global POC Infectious Diseases Market Share by Region (2019-2024)
Table 13. Global POC Infectious Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global POC Infectious Diseases Market Share by Region (2025-2030)
Table 15. POC Infectious Diseases Market Trends
Table 16. POC Infectious Diseases Market Drivers
Table 17. POC Infectious Diseases Market Challenges
Table 18. POC Infectious Diseases Market Restraints
Table 19. Global POC Infectious Diseases Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global POC Infectious Diseases Market Share by Players (2019-2024)
Table 21. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2023)
Table 22. Ranking of Global Top POC Infectious Diseases Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by POC Infectious Diseases Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players POC Infectious Diseases Product Solution and Service
Table 26. Date of Enter into POC Infectious Diseases Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global POC Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global POC Infectious Diseases Revenue Market Share by Type (2019-2024)
Table 30. Global POC Infectious Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global POC Infectious Diseases Revenue Market Share by Type (2025-2030)
Table 32. Global POC Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global POC Infectious Diseases Revenue Market Share by Application (2019-2024)
Table 34. Global POC Infectious Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global POC Infectious Diseases Revenue Market Share by Application (2025-2030)
Table 36. North America POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America POC Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America POC Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe POC Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe POC Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific POC Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific POC Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific POC Infectious Diseases Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America POC Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America POC Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa POC Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa POC Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott POC Infectious Diseases Product
Table 54. Abbott Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Meridian Bioscience Company Detail
Table 57. Meridian Bioscience Business Overview
Table 58. Meridian Bioscience POC Infectious Diseases Product
Table 59. Meridian Bioscience Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 60. Meridian Bioscience Recent Development
Table 61. Orasure Technologies Company Detail
Table 62. Orasure Technologies Business Overview
Table 63. Orasure Technologies POC Infectious Diseases Product
Table 64. Orasure Technologies Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 65. Orasure Technologies Recent Development
Table 66. Trinity Biotech Company Detail
Table 67. Trinity Biotech Business Overview
Table 68. Trinity Biotech POC Infectious Diseases Product
Table 69. Trinity Biotech Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 70. Trinity Biotech Recent Development
Table 71. Beckman Coulter/ Danaher Company Detail
Table 72. Beckman Coulter/ Danaher Business Overview
Table 73. Beckman Coulter/ Danaher POC Infectious Diseases Product
Table 74. Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 75. Beckman Coulter/ Danaher Recent Development
Table 76. Becton Dickinson Company Detail
Table 77. Becton Dickinson Business Overview
Table 78. Becton Dickinson POC Infectious Diseases Product
Table 79. Becton Dickinson Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 80. Becton Dickinson Recent Development
Table 81. Biomerieux Company Detail
Table 82. Biomerieux Business Overview
Table 83. Biomerieux POC Infectious Diseases Product
Table 84. Biomerieux Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 85. Biomerieux Recent Development
Table 86. Bio-Rad Company Detail
Table 87. Bio-Rad Business Overview
Table 88. Bio-Rad POC Infectious Diseases Product
Table 89. Bio-Rad Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 90. Bio-Rad Recent Development
Table 91. Cepheid Company Detail
Table 92. Cepheid Business Overview
Table 93. Cepheid POC Infectious Diseases Product
Table 94. Cepheid Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 95. Cepheid Recent Development
Table 96. Diamedix Company Detail
Table 97. Diamedix Business Overview
Table 98. Diamedix POC Infectious Diseases Product
Table 99. Diamedix Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 100. Diamedix Recent Development
Table 101. Diasorin Company Detail
Table 102. Diasorin Business Overview
Table 103. Diasorin POC Infectious Diseases Product
Table 104. Diasorin Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 105. Diasorin Recent Development
Table 106. Eiken Chemical Company Detail
Table 107. Eiken Chemical Business Overview
Table 108. Eiken Chemical POC Infectious Diseases Product
Table 109. Eiken Chemical Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 110. Eiken Chemical Recent Development
Table 111. Enzo Biochem Company Detail
Table 112. Enzo Biochem Business Overview
Table 113. Enzo Biochem POC Infectious Diseases Product
Table 114. Enzo Biochem Revenue in POC Infectious Diseases Business (2019-2024) & (US$ Million)
Table 115. Enzo Biochem Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global POC Infectious Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global POC Infectious Diseases Market Share by Type: 2023 VS 2030
Figure 3. Flu Features
Figure 4. Adenovirus Features
Figure 5. Malaria Features
Figure 6. Streptococcal Bacteremia Features
Figure 7. Tuberculosis (TB) Features
Figure 8. Occult Blood Features
Figure 9. HIV Features
Figure 10. Global POC Infectious Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global POC Infectious Diseases Market Share by Application: 2023 VS 2030
Figure 12. Hospital& Clinics Case Studies
Figure 13. Clinical Diagnostic Laboratories Case Studies
Figure 14. Homecare Settings Case Studies
Figure 15. POC Infectious Diseases Report Years Considered
Figure 16. Global POC Infectious Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global POC Infectious Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global POC Infectious Diseases Market Share by Region: 2023 VS 2030
Figure 19. Global POC Infectious Diseases Market Share by Players in 2023
Figure 20. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by POC Infectious Diseases Revenue in 2023
Figure 22. North America POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America POC Infectious Diseases Market Share by Country (2019-2030)
Figure 24. United States POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe POC Infectious Diseases Market Share by Country (2019-2030)
Figure 28. Germany POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific POC Infectious Diseases Market Share by Region (2019-2030)
Figure 36. China POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America POC Infectious Diseases Market Share by Country (2019-2030)
Figure 44. Mexico POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa POC Infectious Diseases Market Share by Country (2019-2030)
Figure 48. Turkey POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia POC Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Abbott Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 51. Meridian Bioscience Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 52. Orasure Technologies Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 53. Trinity Biotech Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 54. Beckman Coulter/ Danaher Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 55. Becton Dickinson Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 56. Biomerieux Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 57. Bio-Rad Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 58. Cepheid Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 59. Diamedix Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 60. Diasorin Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 61. Eiken Chemical Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 62. Enzo Biochem Revenue Growth Rate in POC Infectious Diseases Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
